$莱斯康制药(LXRX)$ 8-K - Current report Filed: 2019-07-29 AccNo: 0001193125-19-204244 Size: 40 KBItem 1.02: Termination of a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接